Cytokine networks in neuroinflammation (original) (raw)

• Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context ofan inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24, 179–189 (2006).
  Article CAS PubMed Google Scholar
• Korn, T. et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl Acad. Sci. USA 105, 18460–18465 (2008).
  Article PubMed Google Scholar
• Goverman, J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393–407 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ransohoff, R. M., Kivisakk, P. & Kidd, G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3, 569–581 (2003).
  Article CAS PubMed Google Scholar
• Heppner, F. L., Ransohoff, R. M. & Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358–372 (2015).
  Article CAS PubMed Google Scholar
• Deverman, B. E. & Patterson, P. H. Cytokines and CNS development. Neuron 64, 61–78 (2009).
  Article CAS PubMed Google Scholar
• Hatta, T., Moriyama, K., Nakashima, K., Taga, T. & Otani, H. The Role of gp130 in cerebral cortical development: in vivo functional analysis in a mouse ex utero system. J. Neurosci. 22, 5516–5524 (2002). This paper reveals the role for cytokine receptor signalling, in particular gp130, in mammalian brain development.
  Article CAS PubMed PubMed Central Google Scholar
• Boulanger, L. M. Immune proteins in brain development and synaptic plasticity. Neuron 64, 93–109 (2009).
  Article CAS PubMed Google Scholar
• Adachi, T., Takanaga, H., Kunimoto, M. & Asou, H. Influence of LIF and BMP-2 on differentiation and development of glial cells in primary cultures of embryonic rat cerebral hemisphere. J. Neurosci. Res. 79, 608–615 (2005).
  Article CAS PubMed Google Scholar
• Barnabe-Heider, F. et al. Evidence that embryonic neurons regulate the onset of cortical gliogenesis via cardiotrophin-1. Neuron 48, 253–265 (2005).
  Article CAS PubMed Google Scholar
• Gregg, C. & Weiss, S. CNTF/LIF/gp130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain. Development 132, 565–578 (2005).
  Article CAS PubMed Google Scholar
• Greter, M. et al. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 37, 1050–1060 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13, 753–760 (2012). References 12 and 13 appeared in the same year and described the role of IL-34 in microglia maintenance. They differ, however, in their interpretation of the impact of IL-34 on embryonic microglia development.
  Article CAS PubMed PubMed Central Google Scholar
• Mizuno, T. et al. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-beta neurotoxicity. Am. J. Pathol. 179, 2016–2027 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010). This is a seminal study solidifying that microglia are not bone marrow-derived cells, but instead stem from yolk sac macrophages early during development and are not replenished.
  Article CAS PubMed PubMed Central Google Scholar
• Jin, S. et al. Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells. PLoS ONE 9, e115981 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Streit, W. J. & Graeber, M. B. Heterogeneity of microglial and perivascular cell populations: insights gained from the facial nucleus paradigm. Glia 7, 68–74 (1993).
  Article CAS PubMed Google Scholar
• Chamorro, A. et al. The immunology of acute stroke. Nat. Rev. Neurol. 8, 401–410 (2012).
  Article CAS PubMed Google Scholar
• Waisman, A., Liblau, R. S. & Becher, B. Innate and adaptive immune responses in the CNS. Lancet Neurol. 14, 945–955 (2015).
  Article CAS PubMed Google Scholar
• Walsh, J. G., Muruve, D. A. & Power, C. Inflammasomes in the CNS. Nat. Rev. Neurosci. 15, 84–97 (2014).
  Article CAS PubMed Google Scholar
• Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002).
  Article CAS PubMed Google Scholar
• Crehan, H., Hardy, J. & Pocock, J. Microglia, Alzheimer's disease, and complement. Int. J. Alzheimers Dis. 2012, 983640 (2012).
  PubMed PubMed Central Google Scholar
• Moore, K. J. et al. A CD36-initiated signaling cascade mediates inflammatory effects of β-amyloid. J. Biol. Chem. 277, 47373–47379 (2002).
  Article CAS PubMed Google Scholar
• Lue, L. F. et al. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 171, 29–45 (2001).
  Article CAS PubMed Google Scholar
• Hu, W. T. et al. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79, 897–905 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Griffin, W. S. et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 7611–7615 (1989).
  Article CAS PubMed Google Scholar
• Patel, N. S. et al. Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J. Neuroinflamm. 2, 9 (2005).
  Article CAS Google Scholar
• Gadani, S. P., Walsh, J. T., Smirnov, I., Zheng, J. & Kipnis, J. The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 85, 703–709 (2015). This paper demonstrates that cytokines stored in CNS-resident cells can act as alarmins and trigger reparative immune responses.
  Article CAS PubMed Google Scholar
• Schwartz, M., Kipnis, J., Rivest, S. & Prat, A. How do immune cells support and shape the brain in health, disease, and aging? J. Neurosci. 33, 17587–17596 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Prinz, M., Priller, J., Sisodia, S. S. & Ransohoff, R. M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 14, 1227–1235 (2011).
  Article CAS PubMed Google Scholar
• Chakrabarty, P. et al. Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 24, 548–559 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Chakrabarty, P., Herring, A., Ceballos-Diaz, C., Das, P. & Golde, T. E. Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo. Mol. Neurodegener. 6, 16 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Fillit, H. et al. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett. 129, 318–320 (1991).
  Article CAS PubMed Google Scholar
• Cheng, X., Yang, L., He, P., Li, R. & Shen, Y. Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients. J. Alzheimers Dis. 19, 621–630 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Butchart, J. et al. Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial. Neurology 84, 2161–2168 (2015). A clinical trial of neutralizing TNF in Alzheimer disease.
  Article CAS PubMed PubMed Central Google Scholar
• Ghosh, S. et al. Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J. Neurosci. 33, 5053–5064 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Shaftel, S. S. et al. Chronic interleukin-1β expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J. Neurosci. 27, 9301–9309 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kitazawa, M. et al. Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model. J. Immunol. 187, 6539–6549 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• He, P. et al. Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice. J. Cell Biol. 178, 829–841 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Heneka, M. T. et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674–678 (2013). Demonstration of inflammasome activation in a mouse model of Alzheimer disease.
  Article CAS PubMed Google Scholar
• Vom Berg, J. et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat. Med. 18, 1812–1819 (2012).
  Article CAS PubMed Google Scholar
• Ribizzi, G., Fiordoro, S., Barocci, S., Ferrari, E. & Megna, M. Cytokine polymorphisms and Alzheimer disease: possible associations. Neurol. Sci. 31, 321–325 (2010).
  Article CAS PubMed Google Scholar
• Papassotiropoulos, A. et al. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann. Neurol. 45, 666–668 (1999).
  Article CAS PubMed Google Scholar
• Yu, J. T. et al. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res. 1253, 169–175 (2009).
  Article CAS PubMed Google Scholar
• Nicoll, J. A. et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 47, 365–368 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ben-Nun, A., Wekerle, H. & Cohen, I. R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292, 60–61 (1981).
  Article CAS PubMed Google Scholar
• The International Multiple Sclerosis Genetics Consortium & The Welcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214–219 (2011).
• Kothur, K., Wienholt, L., Brilot, F. & Dale, R. C. CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review. Cytokine 77, 227–237 (2016).
  Article CAS PubMed Google Scholar
• Gutcher, I. & Becher, B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin. Invest. 117, 1119–1127 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13, 715–725 (2000).
  Article CAS PubMed Google Scholar
• Segal, B. M. & Shevach, E. M. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184, 771–775 (1996).
  Article CAS PubMed Google Scholar
• Becher, B., Durell, B. G. & Noelle, R. J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Investig. 110, 493–497 (2002). This is the first report showing that IL-23 and not IL-12 is required for the pathogenesis of EAE.
  Article CAS PubMed Google Scholar
• Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003). Formal demonstration that the IL-23p19 subunit is mandatory for EAE development.
  Article CAS PubMed Google Scholar
• Li, Y. et al. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain 130, 490–501 (2007).
  Article PubMed Google Scholar
• Eugster, H. P., Frei, K., Kopf, M., Lassmann, H. & Fontana, A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28, 2178–2187 (1998).
  Article CAS PubMed Google Scholar
• Sonderegger, I. et al. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205, 2281–2294 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576–587 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Vahedi, G., Kanno, Y., Sartorelli, V. & O'Shea, J. J. Transcription factors and CD4 T cells seeking identity: masters, minions, setters and spikers. Immunology 139, 294–298 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Pepper, M. et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11, 83–89 (2010). This report demonstrates that T H 17 cell polarization is short-lived and that T H 17 cells do not form memory populations.
  Article CAS PubMed Google Scholar
• Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221–225 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005). This paper shows that IL-23 induces a T H cell polarization distinct from T H 1 cells and that IL-23 induces expression of Il17a , among other genes.
  Article CAS PubMed PubMed Central Google Scholar
• Kreymborg, K. et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098–8104 (2007).
  Article CAS PubMed Google Scholar
• Codarri, L. et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560–567 (2011). This report shows that T cells must produce GM-CSF to be encephalitogenic.
  Article CAS PubMed Google Scholar
• Sabat, R., Ouyang, W. & Wolk, K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat. Rev. Drug Discov. 13, 21–38 (2014).
  Article CAS PubMed Google Scholar
• Miossec, P. & Kolls, J. K. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763–776 (2012).
  Article CAS PubMed Google Scholar
• Perriard, G. et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J. Neuroinflamm. 12, 119 (2015).
  Article CAS Google Scholar
• Das Sarma, J. et al. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis. J. Neuroinflamm. 6, 14 (2009).
  Article CAS Google Scholar
• Becher, B. & Segal, B. M. TH17 cytokines in autoimmune neuro-inflammation. Curr. Opin. Immunol. 23, 707–712 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Waisman, A., Hauptmann, J. & Regen, T. The role of IL-17 in CNS diseases. Acta Neuropathol. 129, 625–637 (2015).
  Article CAS PubMed Google Scholar
• Haak, S. et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119, 61–69 (2009).
  CAS PubMed Google Scholar
• Komiyama, Y. et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566–573 (2006).
  Article CAS PubMed Google Scholar
• Kebir, H. et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173–1175 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Huppert, J. et al. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J. 24, 1023–1034 (2010).
  Article CAS PubMed Google Scholar
• Simmons, S. B., Liggitt, D. & Goverman, J. M. Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis. J. Immunol. 193, 555–563 (2014). This report shows that neutrophils are differentially required to mediate tissue damage in the brain but not in the spinal cord, highlighting the difference in response to inflammatory cells in these CNS microenvironments.
  Article CAS PubMed PubMed Central Google Scholar
• Kang, Z. et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32, 414–425 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Renauld, J. C. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol. 3, 667–676 (2003).
  Article CAS PubMed Google Scholar
• Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106–109 (2008).
  Article CAS PubMed Google Scholar
• Duarte, J. H., Di Meglio, P., Hirota, K., Ahlfors, H. & Stockinger, B. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo. PLoS ONE 8, e79819 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Panitch, H. S., Hirsch, R. L., Schindler, J. & Johnson, K. P. Treatment of multiple sclerosis with γ interferon: exacerbations associated with activation of the immune system. Neurology 37, 1097–1102 (1987). An early multiple sclerosis trial showing that treatment with IFN γ exacerbates disease.
  Article CAS PubMed Google Scholar
• Ottum, P. A., Arellano, G., Reyes, L. I., Iruretagoyena, M. & Naves, R. Opposing roles of interferon-γ on cells of the central nervous system in autoimmune neuroinflammation. Front. Immunol. 6, 539 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Simmons, R. D. & Willenborg, D. O. Direct injection of cytokines into the spinal-cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100, 37–42 (1990).
  Article CAS PubMed Google Scholar
• Sethna, M. P. & Lampson, L. A. Immune modulation within the brain – recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-γ. J. Neuroimmunol. 34, 121–132 (1991).
  Article CAS PubMed Google Scholar
• Billiau, A. et al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140, 1506–1510 (1988).
  CAS PubMed Google Scholar
• Steinman, L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13, 139–145 (2007).
  Article CAS PubMed Google Scholar
• Naves, R. et al. The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 191, 2967–2977 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
  Article CAS PubMed Google Scholar
• Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Z. et al. Role of IFN-γ in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J. Clin. Invest. 116, 2434–2441 (2006).
  CAS PubMed PubMed Central Google Scholar
• Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A. & Fu, X. Y. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17, 5328–5337 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Kwidzinski, E. et al. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 19, 1347–1349 (2005).
  Article CAS PubMed Google Scholar
• Lin, W. et al. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 117, 448–456 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ding, X. et al. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity. J. Immunol. 194, 4251–4264 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Hindinger, C. et al. IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability. PLoS ONE 7, e42088 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ni, C. et al. Interferon-γ safeguards blood-brain barrier during experimental autoimmune encephalomyelitis. Am. J. Pathol. 184, 3308–3320 (2014).
  Article CAS PubMed Google Scholar
• Sosa, R. A., Murphey, C., Robinson, R. R. & Forsthuber, T. G. IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation. Proc. Natl Acad. Sci. USA 112, E5038–E5047 (2015).
  Article CAS PubMed Google Scholar
• Wensky, A. K. et al. IFN-γ determines distinct clinical outcomes in autoimmune encephalomyelitis. J. Immunol. 174, 1416–1423 (2005).
  Article CAS PubMed Google Scholar
• Lees, J. R., Golumbek, P. T., Sim, J., Dorsey, D. & Russell, J. H. Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 205, 2633–2642 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kroenke, M. A., Chensue, S. W. & Segal, B. M. EAE mediated by a non-IFN-γ/non-IL-17 pathway. Eur. J. Immunol. 40, 2340–2348 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Baruch, K. et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease. Nat. Med. 22, 135–137 (2016).
  Article CAS PubMed Google Scholar
• Browne, T. C. et al. IFN-γ production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. J. Immunol. 190, 2241–2251 (2013).
  Article CAS PubMed Google Scholar
• Beck, J. et al. Increased production of interferon γ and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78, 318–323 (1988).
  Article CAS PubMed Google Scholar
• Rieckmann, P. et al. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37, 82–88 (1995).
  Article CAS PubMed Google Scholar
• Hovelmeyer, N. et al. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 175, 5875–5884 (2005).
  Article PubMed Google Scholar
• Korn, T., Magnus, T. & Jung, S. Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-α. FASEB J. 19, 1878–1880 (2005).
  Article CAS PubMed Google Scholar
• Rosenman, S. J., Shrikant, P., Dubb, L., Benveniste, E. N. & Ransohoff, R. M. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154, 1888–1899 (1995).
  CAS PubMed Google Scholar
• Benveniste, E. N., Sparacio, S. M. & Bethea, J. R. Tumor necrosis factor-alpha enhances interferon-γ-mediated class II antigen expression on astrocytes. J. Neuroimmunol. 25, 209–219 (1989).
  Article CAS PubMed Google Scholar
• Agresti, C. et al. Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-γ and TNF-α in oligodendrocytes. Eur. J. Neurosci. 10, 2975–2983 (1998).
  Article CAS PubMed Google Scholar
• The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53, 457–465 (1999). This report of a clinical trial shows that TNF-blockade exacerbates multiple sclerosis.
• Mohan, N. et al. Demyelination occurring during anti-tumor necrosis factor α therapy for inflammatory arthritides. Arthritis Rheum. 44, 2862–2869 (2001).
  Article CAS PubMed Google Scholar
• Eugster, H. P. et al. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 29, 626–632 (1999).
  Article CAS PubMed Google Scholar
• Suvannavejh, G. C. et al. Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35–55)-induced experimental autoimmune encephalomyelitis. Cell. Immunol. 205, 24–33 (2000).
  Article CAS PubMed Google Scholar
• Nathan, C. & Cunningham-Bussel, A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol. 13, 349–361 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Naegele, M. et al. Neutrophils in multiple sclerosis are characterized by a primed phenotype. J. Neuroimmunol. 242, 60–71 (2012).
  Article CAS PubMed Google Scholar
• Rumble, J. M. et al. Neutrophil-related factors as biomarkers in EAE and MS. J. Exp. Med. 212, 23–35 (2015). This report suggests a role of CNS-invading neutrophils in neuroinflammation.
  Article CAS PubMed PubMed Central Google Scholar
• Pierson, E. R., Wagner, C. A. & Goverman, J. M. The contribution of neutrophils to CNS autoimmunity. Clin. Immunol. doi:10.1016/j.clim.2016.06.017 (2016).
• McQualter, J. L. et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873–882 (2001). The first paper showing that mice lacking GM-CSF are resistant to the development of EAE.
  Article CAS PubMed PubMed Central Google Scholar
• El-Behi, M. et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568–575 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Croxford, A. L., Spath, S. & Becher, B. GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage. Trends Immunol. 36, 651–662 (2015).
  Article CAS PubMed Google Scholar
• Reynolds, B. C. et al. Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells. Eur. J. Immunol. 44, 3342–3352 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Croxford, A. L. et al. The cytokine GM-CSF drives the inflammatory signature of CCR2(+) monocytes and licenses autoimmunity. Immunity 43, 502–514 (2015). This paper shows that GM-CSF-produced by encephalitogenic T cells targets monocytes to develop into pathogenic-tissue invading phagocytes.
  Article CAS PubMed Google Scholar
• Huang, D. R., Wang, J., Kivisakk, P., Rollins, B. J. & Ransohoff, R. M. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193, 713–726 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Mildner, A. et al. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 132, 2487–2500 (2009). This report shows that monocytes are crucial for the development of EAE.
  Article PubMed Google Scholar
• Izikson, L., Klein, R. S., Charo, I. F., Weiner, H. L. & Luster, A. D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192, 1075–1080 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Fife, B. T., Huffnagle, G. B., Kuziel, W. A. & Karpus, W. J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 899–905 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Gaupp, S., Pitt, D., Kuziel, W. A., Cannella, B. & Raine, C. S. Experimental autoimmune encephalomyelitis (EAE) in CCR2(−/−) mice: susceptibility in multiple strains. Am. J. Pathol. 162, 139–150 (2003).
  Article PubMed PubMed Central Google Scholar
• Yamasaki, R. et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211, 1533–1549 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Vogel, D. Y. et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J. Neuroinflamm. 10, 35 (2013).
  Article CAS Google Scholar
• Heneka, M. T. et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14, 388–405 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Bechmann, I., Galea, I. & Perry, V. H. What is the blood-brain barrier (not)? Trends Immunol. 28, 5–11 (2007).
  Article CAS PubMed Google Scholar
• Perry, V. H., Anthony, D. C., Bolton, S. J. & Brown, H. C. The blood-brain barrier and the inflammatory response. Mol. Med. Today 3, 335–341 (1997).
  Article CAS PubMed Google Scholar
• Billingham, R. E. & Boswell, T. Studies on the problem of corneal homografts. Proc. R. Soc. B Biol. Sci. 141, 392–406 (1953).
  Article CAS Google Scholar
• Galea, I., Bechmann, I. & Perry, V. H. What is immune privilege (not)? Trends Immunol. 28, 12–18 (2007).
  Article CAS PubMed Google Scholar
• Rothhammer, V. & Quintana, F. J. Control of autoimmune CNS inflammation by astrocytes. Semin. Immunopathol. 37, 625–638 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Schreiner, B. et al. Astrocyte depletion impairs redox homeostasis and triggers neuronal loss in the adult CNS. Cell Rep. 12, 1377–1384 (2015).
  Article CAS PubMed Google Scholar
• Ransohoff, R. M. & El Khoury, J. Microglia in Health and Disease. Cold Spring Harb. Perspect. Biol. 8 (2015).
• Goldmann, T. et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol. 17, 797–805 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Kivisakk, P. et al. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann. Neurol. 65, 457–469 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11, 328–334 (2005).
  Article CAS PubMed Google Scholar
• Guilliams, M. et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14, 571–578 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Dominguez, P. M. & Ardavin, C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 234, 90–104 (2010).
  Article CAS PubMed Google Scholar
• Neal, J. W. & Gasque, P. How does the brain limit the severity of inflammation and tissue injury during bacterial meningitis? J. Neuropathol. Exp. Neurol. 72, 370–385 (2013).
  Article CAS PubMed Google Scholar